Search research articles
Contact Us
Filters
Showing results (1001-1010 of 2,335) with videos related to
Page
of 234
Sort By:
Hybridoma
|
August 1, 1988
Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody
T F Bumol, P Marder, S V DeHerdt, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 24, 2005
A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease
Anjan Chatterjee, Karen E Anderson, Carol B Moskowitz, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 1, 1991
Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production
R M Schultz, P Marder, S M Spaethe, et al.
Gait & Posture
|
December 30, 2008
Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness
Ashwini K Rao, Lisa Muratori, Elan D Louis, et al.
The American Journal of Psychiatry
|
November 13, 1998
Informed consent: assessment of comprehension
D A Wirshing, W C Wirshing, S R Marder, et al.
ACS Applied Materials & Interfaces
|
November 7, 2012
Experimental study of interfacial fracture toughness in a SiN(x)/PMMA barrier film
Yongjin Kim, Anuradha Bulusu, Anthony J Giordano, et al.
The Journal of Organic Chemistry
|
August 25, 2020
New Design Strategy Toward NIR I Xanthene-Based Dyes
Ishanka Rajapaksha, Hao Chang, Yao Xiong, et al.
Chemical Reviews
|
April 2, 2024
Applications of Transition Metal-Catalyzed <i>ortho</i>-Fluorine-Directed C-H Functionalization of (Poly)fluoroarenes in Organic Synthesis
Yudha P Budiman, Robin N Perutz, Patrick G Steel, et al.
Frontiers in Immunology
|
April 18, 2025
Corrigendum: Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial
Abdul Abdellatif, Lin Zhao, Katie Obermeyer, et al.
Chemical Communications (Cambridge, England)
|
December 13, 2021
Cu-mediated <i>vs.</i> Cu-free selective borylation of aryl alkyl sulfones
Mingming Huang, Man Tang, Jiefeng Hu, et al.
Page
of 234
Search research articles
Search
Showing results (1001-1010 of 2,335) with videos related to
Sort By:
Page
of 234
Hybridoma
|
August 1, 1988
Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody
T F Bumol, P Marder, S V DeHerdt, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 24, 2005
A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease
Anjan Chatterjee, Karen E Anderson, Carol B Moskowitz, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 1, 1991
Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production
R M Schultz, P Marder, S M Spaethe, et al.
Gait & Posture
|
December 30, 2008
Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness
Ashwini K Rao, Lisa Muratori, Elan D Louis, et al.
The American Journal of Psychiatry
|
November 13, 1998
Informed consent: assessment of comprehension
D A Wirshing, W C Wirshing, S R Marder, et al.
ACS Applied Materials & Interfaces
|
November 7, 2012
Experimental study of interfacial fracture toughness in a SiN(x)/PMMA barrier film
Yongjin Kim, Anuradha Bulusu, Anthony J Giordano, et al.
The Journal of Organic Chemistry
|
August 25, 2020
New Design Strategy Toward NIR I Xanthene-Based Dyes
Ishanka Rajapaksha, Hao Chang, Yao Xiong, et al.
Chemical Reviews
|
April 2, 2024
Applications of Transition Metal-Catalyzed <i>ortho</i>-Fluorine-Directed C-H Functionalization of (Poly)fluoroarenes in Organic Synthesis
Yudha P Budiman, Robin N Perutz, Patrick G Steel, et al.
Frontiers in Immunology
|
April 18, 2025
Corrigendum: Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial
Abdul Abdellatif, Lin Zhao, Katie Obermeyer, et al.
Chemical Communications (Cambridge, England)
|
December 13, 2021
Cu-mediated <i>vs.</i> Cu-free selective borylation of aryl alkyl sulfones
Mingming Huang, Man Tang, Jiefeng Hu, et al.
Page
of 234